BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35069909)

  • 1. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 5. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 6. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
    Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
    Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
    Zhao J; Quan J; Chen W; Xie X
    Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
    Lin Y; Xie H; Zhao W; Li Y; Zhang Z
    Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer.
    Luo H; Luo J; Ding N; Zhang T; He Y
    Pharmgenomics Pers Med; 2023; 16():1109-1126. PubMed ID: 38149287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
    Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
    Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
    Cui F; Wang W; Zhuang C; He D; Wang P
    Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer.
    Li TH; Wang YY; Zhao BB; Qin C; Li ZR; Wang WB
    Heliyon; 2022 Sep; 8(9):e10416. PubMed ID: 36091946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.